SCHEMBL4640990

SCHEMBL4640990

CC(C)(C)OC(=O)NCCCCNc1nc2ccccc2[nH]1

nearest known ligand 0.87

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 2/20 0.87
▸ TRPC3 Q13507 1/20 0.57
▸ TRPC4 Q9UBN4 1/20 0.57
▸ TRPC5 Q9UL62 1/20 0.57
▸ KCNH2 Q12809 2/20 0.55
▸ BRD4 O60885 4/20 0.54
▸ TSHR P16473 1/20 0.52
▸ LMNA P02545 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.46
▸ ALPL P05186 2/20 0.46
▸ ALPG P10696 2/20 0.46
▸ PLAA Q9Y263 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445116 0.90 BCHE (0.74) BCHETRPC3TRPC4TRPC5KCNH2
SCHEMBL8329416 0.82 BCHE (0.66) BCHELMNAALDH1A1SMN1; SMN2
SCHEMBL2086623 0.82 BCHE (0.62) BCHEBRD4TSHRLMNAALDH1A1
SCHEMBL2084432 0.80 BCHE (0.60) BCHEBRD4TSHRALDH1A1
SCHEMBL13609711 0.80 BCHE (0.69) BCHELMNANPC1ALDH1A1RAB9A
SCHEMBL6304380 0.80 BCHE (0.69) BCHETSHRLMNAALDH1A1SMN1; SMN2
SCHEMBL22598624 0.79 BCHE (0.59) BCHEBRD4TDP1ALDH1A1
SCHEMBL5144365 0.79 BCHE (0.61) BCHETSHRLMNAALDH1A1RAB9A
SCHEMBL20232505 0.78 BCHE (0.60) BCHEBRD4ALDH1A1
SCHEMBL29642307 0.78 BCHE (0.60) BCHEBRD4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0853084-B1 Substituted purine derivatives as vitronectin receptor antagonists HOECHST AG (DE) 2008-08-13 — — EP disclosed
US-6723727-B1 VITRONECTIN RECEPTOR ANTAGONISTS; INHIBITORS OF BONE RESORPTION; OSTEOPOROSIS HOECHST AKTIENGESELLSCHAFT (DE) 2004-04-20 — — US disclosed
EP-0853084-A2 Substituted purine derivatives as vitronectin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-07-15 — — EP disclosed
Send feedback